Page 1

XpresSpa Group XpresSpa Group Announces Second Quarter 2021 Financial Results and Provides Business Update August 16 , 2021 Record MSA Practice Patient Fees Increases to $ 17.1 Million in Q2 against $ 6.3 Million in Q1 Net revenue of $ 9.1 Million , including $ 8.7 Million from XpresCheck ™ Net Loss Narrows to $ 4.7 Million Compared to Net Loss of $ 58.5 Million in Prior Year Second Quarter Strong Liquidity Position with Unrestricted Cash Balance of $ 102.5 Million Re - opening an Additional Eight to Ten Legacy XpresSpa Locations this Fall Launched Phase 2 of Treat TM Today - Mobile App Launching Phase 3 of Treat this Fall - Locations in New York JFK International Airport and Phoenix Sky Harbor Airport Webcast and Conference Call Scheduled for 4:30 PM ET Today NEW YORK , Aug. 16 , 2021 ( GLOBE NEWSWIRE ) -- XpresSpa Group , Inc. ( Nasdaq : XSPA ) , a travel health and wellness company , today announced that it has filed financial results on Form 10 - Q for the second quarter ending June 30 , 2021 and provided a business update . Doug Satzman , XpresSpa Group CEO , stated , " We are pleased to have reported $ 9.1 million in total revenue during the second quarter , including $ 8.7 million related to XpresCheck , and to have substantially narrowed our Adjusted EBITDA loss and net loss compared to the prior year . At the onset of the pandemic last March , we saw an opportunity for COVID - 19 testing at major U.S. airports and moved quickly to realize that vision . Since then , XpresCheck has vastly surpassed our expectations as testing numbers continue to increase due to the resumption of travel . The MSA patient practice fees alone increased to $ 17.1 million in Q2 over $ 6.3 million in Q1 . Additionally , our collaborations with major airlines and government agencies demonstrates their confidence in XpresCheck . We firmly believe that due to the emergence of more highly contagious COVID - 19 variants such as Delta , along with break - through vaccination infections , testing will remain an important part of travel , especially international travel , for the foreseeable future . In addition , we have seen encouraging results after re - opening our first four high performing legacy XpresSpa locations and see a path towards restoring profitability which is leading us to re - open the next wave of previously high performing stores this fall . " Mr. Satzman added , " We are thrilled to have launched Phases 1 and 2 of our new travel , health and wellness brand , Treat , ahead of schedule . Phase 1 , our website and brand campaign , launched on June 1 , and today , we launched Phase 2 , our mobile app . Phase 3 , the opening of our first two integrated health and wellness Treat airport locations , will occur this fall . Through Treat , we are leveraging XpresSpa's historic travel wellness experience and XpresCheck's healthcare expertise to provide 24/7 , on - demand access to integrated healthcare through technology and personalized services . We believe Treat can ultimately become a leader in this emerging new category of travel health and wellness . " Mr. zman concluded , believe that there is significant opportunity for three sustainable growth brands , with healthy nit level economics , that can run adjacent to each other and leverage an efficient corporate structure as well as our relationships and experience operating in global airports . With a clear vision and a strong management team in place , we remain focused on elevating our brands , being nimble , further expanding our services and products to increase market share and increase value for shareholders . " Business Update XpresCheckTM Wellness Centers XpresCheck provides COVID - 19 testing to the frontline airport workforce and passengers across thirteen locations in eleven airports . XpresCheck's medical team of state licensed physicians and nurse practitioners operate under management services agreements and administer COVID - 19 testing options including a rapid molecular COVID - 19 test , a Polymerase Chain Reaction ( PCR ) test , and a rapid PCR test . The Company believes that COVID - 19 testing will remain an important and necessary service for airline employees , airport staff , and passengers for the foreseeable future . This is due to various factors including COVID - 19 variants , international travel requirements , and break - through vaccination infection rates . Developments since the onset of the second quarter 2021 include : • On April 5th , XpresCheck announced that it had signed an agreement with Delta Air Lines to administer the new rapid antigen test to passengers traveling from JFK International Airport to Milan Malpensa and Rome - Fiumicino International Airports . • On April 7th , XpresCheck opened a COVID - 19 testing facility at Seattle - Tacoma International Airport ( SEA ) pre - security inside the terminal , in the Baggage Claim area near Carousel 9 . • On April 21st , XpresCheck opened a COVID - 19 testing facility at San Francisco International Airport ( SFO ) pre - security , near the baggage claim area on the Arrivals level at Terminal 3 . • On July 30th , XpresCheck announced its collaboration with the World Health Organization ( WHO ) Foundation to promote the " Go Give One " campaign , dedicated to delivering COVID - 19 vaccines worldwide in the fight to reduce the growing vaccine equity gap . As a kick - off to the campaign , the Company is matching customer donations up to $ 100,000